California’s low-cost insulin plans receive $100m manufacturing boost
Pharmaceutical Technology
JULY 15, 2022
CivicaRx is a non-profit generic drug company producing affordable insulin biosimilars in collaboration with the Juvenile Diabetes Research Foundation (JDRF). A PhRMA spokesperson told Pharmaceutical Technology that health insurance plans and pharmacy benefit managers (PBMs) pay less today for insulin than they did 15 years ago.
Let's personalize your content